The aim of this paper is not to outline a specific medical-surgical algorithm for managing PPH, but rather to give an overview for system-wide preparedness that should be considered in planning to mitigate this frequent, potentially life-threatening, obstetrical emergency.
Interim data from two studies of a dapivirine vaginal ring—DREAM and HOPE—lend further credence to the potential benefits of using the device for HIV prevention. Plus: FDA authorizes direct-to-consumer BRCA1/BRCA2 test. Also: A new Zika virus test extends window for accurate diagnosis.
Women who smoke cigarettes may be more susceptible to urogenital infections and have more vaginal malodor, according to a cross-sectional study.
Planning up front for an endoscopic gynecologic surgical procedure is the best way to prevent an injury or complication.
In the second part of Dr. Lockwood's editorial on opioids, he discusses steps that ob/gyns can take to help limit opioid use disorder in our pregnant and non-pregnant patients.
A collection of standards, guidelines, tools and articles for the OB managing postpartum hemorrhage.
James Greenberg, MD, reviews the LaparoVue Visibility System, a single-use, disposable system designed to eliminate fogging while cleaning laparoscopes and trocars during a procedure.
Ob/gyns are on the front line of the opioid epidemic and have a responsibility to recognize, treat, refer, and advocate for pregnant women with opioid use disorder.
According to a literature review, apart from the essential role that sex hormones play in modulating hypoactive sexual desire disorder (HSDD) through therapeutic interventions, a comprehensive understanding of the biologic mechanisms underlying the disorder is imperative.
In a new statement, the US Preventive Services Task Force (USPSTF) is recommending against ovarian cancer screening for women who have no symptoms and no hereditary cancer syndromes. Plus: Breast MRI screening results in higher biopsy rates, according to a study.